Quinlukast

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameQuinlukast
Drug Alias NameVUFB-19363
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene receptor antagonists
TargetsLeukotriene receptor
Therapy Area/IndicationsInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVufb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVufbZentiva As
Active IndicationsN/A
Inactive IndicationsInflammationAsthma

Other Information

ATC CodeN/A
Related LinksN/A